AboutInVivoMAbanti-mouseIL-9
The9C1monoclonalantibodyreactswithmouseIL-9,apleiotropiccytokineexpressedbyTh9cells,Th2cells,Th17cells,regulatoryTcells,NKTcells,ILC2s,andmastcells.IL-9promotesmastcellandTcellproliferation,stimulatesmastcellaccumulationintissues,promotesILCsurvival,enhancesclass-switchingtoIgEinBcellsandaltershaematopoieticProgenitorcellactivity.Additionally,IL-9enhancesmucusproductionfromairwayepithelialcellsandaltersbarrierfunctionintheintestines.IL-9isthoughttocontributetoasthma.The9C1antibodyhasbeenreportedtoblockthebioactivityofIL-9.
InVivoMAbanti-mouseIL-9Specifications
| Isotype | MouseIgG2a |
| RecommendedIsotypeControl(s) | InVivoMAbmouseIgG2aisotypecontrol,unknownspecificity(BE0085) |
| RecommendedInVivoPureDilutionBuffer | InVivoPurepH7.0DilutionBuffer(IP0070) |
| Immunogen | MouseIL-9-OVAcomplex |
| ReportedApplications | invivoIL-9neutralization |
| Endotoxin |
|
| Purity |
|
| Formulation |
|
| Sterility | 0.2μMfiltered |
| Production | Purifiedfromtissueculturesupernatantinananimalfreefacility |
| Purification | ProteinG |
| Storage | Theantibodysolutionshouldbestoredundilutedat4°C,andprotectedfromprolongedexposuretolight.Donotfreeze. |
| RRID | AB_10950648 |
